Economic and clinical impact of a novel, light-based, at-home antiviral treatment on mild-to-moderate COVID-19

Scott Gibson, Rhodri Saunders , Nathan Stasko , Cherrishe-Brown Bickerstaff , John Oakley , Mark Osterman , Rafael Torrejon Torres , Jonathan K. Kish , Bruce A. Feinberg & David Emerson

Keywords: covid-19; economic model; antiviral treatment; health care costs; hospitalization; USA

Journal of Medical Economics